The trading price of Citius Pharmaceuticals Inc (NASDAQ:CTXR) floating higher at last check on Monday, April 01, closing at $0.98, 9.22% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $1.71 and a 52-week low of $0.60. Over the past month, the stock has gained 27.55% in value.
Citius Pharmaceuticals Inc, whose market valuation is $155.91 million at the time of this writing, is expected to release its quarterly earnings report May 10, 2024 – May 14, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.05 per share this quarter, however they have predicted annual earnings per share of -$0.21 for 2024 and $0.12 for 2025. It means analysts are expecting annual earnings per share growth of 4.50% this year and 157.10% next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $61.72 million.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Citius Pharmaceuticals Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CTXR has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that CTXR’s price is currently 29.42% off the SMA20 and 35.53% off the SMA50. The RSI metric on the 14-day chart is currently showing 74.63, and weekly volatility stands at 9.03%. When measured over the past 30 days, the indicator reaches 7.50%. Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s beta value is currently sitting at 1.45, while the Average True Range indicator is currently displaying 0.06.
To see how Citius Pharmaceuticals Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: CTXR stock’s performance was 9.22% at last check in today’s session, and -10.91% in the past year.
An evaluation of the daily trading volume of Citius Pharmaceuticals Inc (NASDAQ:CTXR) indicates that the 3-month average is 677.17K. However, this figure has increased over the past 10 days to an average of 0.71 million.
Currently, records show that 158.86 million of the company’s shares remain outstanding. The insiders hold 7.74% of outstanding shares, whereas institutions hold 16.96%. The stats also highlight that short interest as of Mar 15, 2024, stood at 12.18 million shares, resulting in a short ratio of 20.62 at that time. From this, we can conclude that short interest is 7.66% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 11.58 million. However, since the stock’s price has seen 29.54% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
